Angewandte
Chemie
DOI: 10.1002/anie.201201804
Asymmetric Catalysis
Highly Diastereo- and Enantioselective Synthesis of a-Alkyl Norstatine
Derivatives: Catalytic Asymmetric Mannich Reactions of 5H-Oxazol-
4-ones**
Depeng Zhao, Linqing Wang, Dongxu Yang, Yixin Zhang, and Rui Wang*
The catalytic asymmetric synthesis of b-amino acids[1] has
been an intense area of research in recent years as these
unnatural amino acids are basic elements of peptides and
peptidomimetic precursors of many physiologically active
compounds.[2] In particular, many efforts have focused on
synthetic methods towards a-hydroxy b-amino acid (norsta-
tine) derivatives,[3] which have been used as a side chain in
taxol analogues,[4] and are observed in natural products such
as leuhistin.[5] Despite previous success, the stereoselective
synthesis of a-alkyl a-hydroxy b-amino acids bearing a qua-
ternary stereogenic center is still challenging.
In 2010, Wolfe and co-workers described an asymmetric
tandem Wittig rearrangement/Mannich reaction to prepare
such compounds using 2-phenylcyclohexanol as a chiral
auxiliary (Scheme 1a).[6] With this protocol, both syn- and
anti-selective products were accessed with high enantioselec-
Scheme 1. Protocols for asymmetric synthesis of a-alkyl a-hydroxy b-
amino acids.
tivities and diastereoselectivities using specific protective
groups. To date, only a few catalytic methods have been
developed for a-alkyl norstatine derivatives.[7] Hu, Gong, and
co-workers reported a three-component reaction of diazo
compounds with alcohols and imines catalyzed by [Rh2-
(OAc)4] and a chiral Brønsted acid (Scheme 1b). In this
process, anti-a-aryl norstatine derivatives were synthesized in
high yields with excellent enantioselectivities.[7] In view of
previous failures of the direct Mannich reaction of a-alkyl a-
hydroxy acids derivatives,[8] we envisioned that the 5H-
oxazol-4-ones[9] 2 might serve as highly reactive equivalents
of a-alkyl a-hydroxy acids and undergo an asymmetric
Mannich reaction,[10] an efficient approach to these com-
pounds (Scheme 1c). The high reactivity of 5H-oxazol-4-one
compared to other equivalents of a-alkyl a-hydroxy acids is
attributed to the aromatization resulting from the enolization
of 5H-oxazol-4-one, thus enabling the intermediates to be
more stable and thereby increasing the reactivity. Herein we
describe our efforts on this subject, and the resulting access to
a series of syn-a-alkyl norstatine derivatives with high
enantioselectivities and diastereoselectivities.
Given our continued interest in the asymmetric synthesis
of unnatural amino acids,[11] especially oxazolones,[12,13] we
decided to investigate the asymmetric Mannich reaction of
the 5H-oxazol-4-ones 2. Fortunately, we found that the
reaction between the N-Dpp (Dpp = diphenylphosphinoyl)
imine 1a and 5H-oxazol-4-one 2a could be efficiently
catalyzed by a zinc catalyst[14] such as the salen 4/Zn complex
(Scheme 2). The Mannich adducts can be obtained with good
yield and excellent diastereoselectivity, though with low
enantioselectivity in the presence of salen 4/Zn (78%,
7% ee, 20:1 d.r.) at room temperature. Encouraged by these
results, a series of salen-type ligands, 5–7, were synthesized
including the dinuclear zinc ligand 7. These salen/Zn catalysts
were also found to be ineffective for the current Mannich
reaction. In addition, the substituted binol 8 was tested and
resulted in low conversion. Interestingly, when the thienyl-
ProPhenol ligand L1[15] was employed for the reaction, an
encouraging ee value was obtained along with excellent
diastereoselectivity. In contrast, the phenyl ligand L2 gave
low diastereoselectivity under the same reaction conditions.
With these results in hand, we then tried to optimize the
Mannich reaction with L1/Et2Zn by changing variables such
as reaction temperature and solvent. In running the reaction
at lower temperatures, we were satisfied to find that the
ee value increased to 50% at 08C and 67% at À208C with
[*] Dr. D. Zhao,[+] L. Wang,[+] D. Yang, Y. Zhang, Prof. Dr. R. Wang
Key Laboratory of Preclinical Study for New Drugs of Gansu
Province, School of Basic Medical Sciences, and Institute of
Biochemistry and Molecular Biology, School of Life Sciences
Lanzhou University, Lanzhou, 730000 (P.R. China)
E-mail: wangrui@lzu.edu.cn
[+] These authors contributed equally to this work.
[**] We are grateful for grants from the National Natural Science
Foundation of China (nos. 90813012 and 20932003), the Key
National S&T Program “Major New Drug Development” of the
Ministry of Science and Technology (2012ZX09504001-003), and the
Scholarship Award for Distinguished Doctoral Candidates of
Lanzhou University.
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2012, 51, 1 – 6
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1
These are not the final page numbers!